Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by Cavailles
Group name EquipeVC
Item Type Journal Article
Title An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor ? (RAR?, NR1B2) Selective Agonist
Creator Nadendla et al.
Author Eswarkumar Nadendla
Author Catherine Teyssier
Author Vanessa Delfosse
Author Valérie Vivat
Author Gunasekaran Krishnasamy
Author Hinrich Gronemeyer
Author William Bourguet
Author Pierre Germain
Abstract Retinoic acid is an important regulator of cell differentiation which plays major roles in embryonic development and tissue remodeling. The biological action of retinoic acid is mediated by three nuclear receptors denoted RAR?, ? and ?. Multiple studies support that RAR? possesses functional characteristics of a tumor suppressor and indeed, its expression is frequently lost in neoplastic tissues. However, it has been recently reported that RAR? could also play a role in mammary gland tumorigenesis, thus demonstrating the important but yet incompletely understood function of this receptor in cancer development. As a consequence, there is a great need for RAR?-selective agonists and antagonists as tools to facilitate the pharmacological analysis of this protein in vitro and in vivo as well as for potential therapeutic interventions. Here we provide experimental evidences that the novel synthetic retinoid BMS948 is an RAR?-selective ligand exhibiting a full transcriptional agonistic activity and activating RAR? as efficiently as the reference agonist TTNPB. In addition, we solved the crystal structures of the RAR? ligand-binding domain in complex with BMS948 and two related compounds, BMS641 and BMS411. These structures provided a rationale to explain how a single retinoid can be at the same time an RAR? antagonist and an RAR? full agonist, and revealed the structural basis of partial agonism. Finally, in addition to revealing that a flip by 180° of the amide linker, that usually confers RAR? selectivity, accounts for the RAR? selectivity of BMS948, the structural analysis uncovers guidelines for the rational design of RAR?-selective antagonists.
Publication PloS One
Volume 10
Issue 5
Pages e0123195
Date 2015
Journal Abbr PLoS ONE
Language eng
DOI 10.1371/journal.pone.0123195
ISSN 1932-6203
Library Catalog PubMed
Extra PMID: 25933005 PMCID: PMC4416907
Tags Crystallography, X-Ray, HeLa Cells, Humans, Imidazoles, Ligands, Models, Molecular, original, Protein Binding, Protein Structure, Tertiary, Receptors, Retinoic Acid, Retinoic Acid Receptor alpha, Structure-Activity Relationship
Date Added 2019/05/16 - 11:32:07
Date Modified 2019/05/16 - 11:36:39
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés